speb/financial-data huggingface dataset:
Financial ratios for CVLG — annual report dated 2022-12-31
Total revenue: 1216858000
Gross profit: 185985000
Operating income: 80360000
Net income: 108682000
Capital expenditures: 47466000
Operating cash flow: 159230000
Depreciation & amortization: 57512000
Net tangible assets: 270742000
Owner earnings: 118728000
Return on net tangible assets (%): 43.852819289212604
Capex to operating income (%): 59.06669985067198
Buffett classification: The Good
Stock price: 16.71
P/E ratio: 3.1474413995877883
Shares outstanding: 20470989
Book value: 377128000
P/B ratio: 0.9070401195084957
Market cap (USD): 342070226.19
Debt to equity: 0.4763077787912857
Current ratio: 1.426175850782406
Quick ratio: 1.403654857450311
Effective tax rate (%): 24.413132388369096
Interest coverage ratio: 26.065520596821276
COGS to revenue (%): 84.71596521533326
SG&A to revenue (%): 7.699665860766006
Free cash flow (dilution-adjusted): 52175000
Buyback yield (%): 24.767721220186328
Retained earnings: 329471000
Inventory turnover: 293.1948236632537
Receivables turnover: 9.476644393564163
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.545977980528441
FCF margin (%): 4.2876818823560345
Rule of 40 score: 4.2876818823560345
Financial ratios for CVLG — annual report dated 2023-12-31
Total revenue: 1103573000
Gross profit: 164202000
Operating income: 46238000
Net income: 55229000
Capital expenditures: 125783000
Operating cash flow: 84841000
Depreciation & amortization: 69943000
Net tangible assets: 228058000
Owner earnings: -611000
Return on net tangible assets (%): -0.2679143025019951
Capex to operating income (%): 272.0338249924305
Buffett classification: The Gruesome
Stock price: 22.49
P/E ratio: 8.336065157978599
Shares outstanding: 20470989
Book value: 403420000
P/B ratio: 1.141223892246294
Market cap (USD): 460392542.60999995
Debt to equity: 0.7274403847107234
Current ratio: 1.0919249989723474
Quick ratio: 1.0634560839973928
Effective tax rate (%): 24.37846068660022
Interest coverage ratio: 5.803690222166437
COGS to revenue (%): 85.1208755560348
SG&A to revenue (%): 9.47422599139341
Free cash flow (dilution-adjusted): -139866000
Buyback yield (%): 5.523547331117793
Retained earnings: 378919000
Inventory turnover: 193.76464521452147
Receivables turnover: 7.18425232732244
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.8965984694196365
FCF margin (%): -12.673923700561721
Revenue growth (%): -9.309631855154834
Rule of 40 score: -21.983555555716556
Financial ratios for CVLG — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25.99
Shares outstanding: 20470989
Market cap (USD): 532041004.10999995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVLG — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 26.86
Shares outstanding: 20470989
Market cap (USD): 549850764.54
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVLG — annual report dated 2024-12-31
Total revenue: 1131476000
Gross profit: 189649000
Operating income: 46390000
Net income: 35921000
Capital expenditures: 102522000
Operating cash flow: 122893000
Depreciation & amortization: 86529000
Net tangible assets: 269273000
Owner earnings: 19928000
Return on net tangible assets (%): 7.400667723834175
Capex to operating income (%): 221.00021556369907
Buffett classification: The Gruesome
Stock price: 26.86
P/E ratio: 15.307223199242783
Shares outstanding: 20470989
Book value: 438340000
P/B ratio: 1.2543933123602682
Market cap (USD): 549850764.54
Debt to equity: 0.6773030067983757
Current ratio: 1.1796863363802357
Quick ratio: 1.1485295983494872
Effective tax rate (%): 23.042900407434036
Interest coverage ratio: 3.417059516794343
COGS to revenue (%): 83.2387960504686
SG&A to revenue (%): 11.604753437103394
Free cash flow (dilution-adjusted): -33760000
Buyback yield (%): 0
Retained earnings: 278133000
Inventory turnover: 166.75407223796034
Receivables turnover: 7.437413315980097
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.683022353547938
FCF margin (%): -2.9837133089875527
Revenue growth (%): 2.5284235841217573
Rule of 40 score: -0.45528972486579544
Financial ratios for CVLG — quarterly report dated 2025-03-31
Total revenue: 269355000
Gross profit: 41885000
Operating income: 7953000
Net income: 6563000
Capital expenditures: 23943000
Operating cash flow: 24830000
Depreciation & amortization: 21795000
Net tangible assets: 266546000
Owner earnings: 4415000
Return on net tangible assets (%): 1.6563745094655329
Capex to operating income (%): 301.0562052055828
Buffett classification: The Gruesome
Stock price: 21.94
P/E ratio: 17.10854405988115
Shares outstanding: 20470989
Book value: 443644000
P/B ratio: 1.012373656941151
Market cap (USD): 449133498.66
Debt to equity: 0.6270162562775559
Current ratio: 1.0941613969312793
Quick ratio: 1.0607110034509413
Effective tax rate (%): 23.20383805289024
Interest coverage ratio: 2.783689184459223
COGS to revenue (%): 84.44988955096434
SG&A to revenue (%): 11.266172894507248
Free cash flow (dilution-adjusted): -9606000
Buyback yield (%): 0
Retained earnings: 282838000
Inventory turnover: 41.388282387190685
Receivables turnover: 1.8565579702652963
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9750314466950935
FCF margin (%): -3.5662972656902605
Rule of 40 score: -3.5662972656902605
Financial ratios for CVLG — quarterly report dated 2025-06-30
Total revenue: 302854000
Gross profit: 48739000
Operating income: 11858000
Net income: 9840000
Capital expenditures: 28867000
Operating cash flow: 21907000
Depreciation & amortization: 23121000
Net tangible assets: 241727000
Owner earnings: 4094000
Return on net tangible assets (%): 1.6936461379986514
Capex to operating income (%): 243.43902850396356
Buffett classification: The Gruesome
Stock price: 23.9
P/E ratio: 29.827265567274278
Shares outstanding: 20470989
Book value: 416874000
P/B ratio: 1.1736319297917357
Market cap (USD): 489256637.09999996
Debt to equity: 0.7449229263518473
Current ratio: 1.0926304674039904
Quick ratio: 1.0626743733674207
Effective tax rate (%): 26.352817902851584
Interest coverage ratio: 4.80080971659919
COGS to revenue (%): 83.90676695701559
SG&A to revenue (%): 11.043274977381841
Free cash flow (dilution-adjusted): -15452000
Buyback yield (%): 0
Retained earnings: 290881000
Inventory turnover: 47.1456400742115
Receivables turnover: 1.8874229553967057
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.430118601672532
FCF margin (%): -5.102128418313775
Revenue growth (%): 12.436747043864045
Rule of 40 score: 7.33461862555027
Financial ratios for CVLG — quarterly report dated 2025-09-30
Total revenue: 296889000
Gross profit: 42425000
Operating income: 7439000
Net income: 9093000
Capital expenditures: 35583000
Operating cash flow: 41364000
Depreciation & amortization: 22953000
Net tangible assets: 251216000
Owner earnings: -3537000
Return on net tangible assets (%): -1.4079517228202025
Capex to operating income (%): 478.3304207554779
Buffett classification: The Gruesome
Stock price: 21.54
P/E ratio: 17.294677716504548
Shares outstanding: 20470989
Book value: 423716000
P/B ratio: 1.0406619128378443
Market cap (USD): 440945103.06
Debt to equity: 0.7295122204495464
Current ratio: 1.011078777800873
Quick ratio: 0.9791467470380378
Effective tax rate (%): 22.050771528123445
Interest coverage ratio: 2.145040369088812
COGS to revenue (%): 85.71014756356753
SG&A to revenue (%): 10.671328341568733
Free cash flow (dilution-adjusted): -8881000
Buyback yield (%): 0.23064095574310425
Retained earnings: 298221000
Inventory turnover: 41.40992676973149
Receivables turnover: 1.8112264818565607
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8932945866756328
FCF margin (%): -2.991353670900572
Revenue growth (%): -1.9695959109009624
Rule of 40 score: -4.960949581801534
Financial ratios for CVLG — quarterly report dated 2025-12-31
Total revenue: 295374000
Gross profit: 36883000
Operating income: -6783000
Net income: -18257000
Capital expenditures: 23659000
Operating cash flow: 25547000
Depreciation & amortization: 24857000
Net tangible assets: 217910000
Owner earnings: -17059000
Return on net tangible assets (%): -7.828461291358818
Buffett classification: The Gruesome
Stock price: 21.99
P/E ratio: 62.18497694571073
Shares outstanding: 20470989
Book value: 403996000
P/B ratio: 1.1142611513727858
Market cap (USD): 450157048.10999995
Debt to equity: 0.8383696868285825
Current ratio: 1.1087875872710475
Quick ratio: 1.078584423130042
Interest coverage ratio: -2.080674846625767
COGS to revenue (%): 87.513118961046
SG&A to revenue (%): 13.615280965826376
Free cash flow (dilution-adjusted): -3553000
Buyback yield (%): 0.0015550128625975632
Retained earnings: 278210000
Inventory turnover: 40.758593503626614
Receivables turnover: 1.7018062397372742
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.8117811793147193
FCF margin (%): -1.2028817702302843
Revenue growth (%): -0.5102917251902226
Rule of 40 score: -1.713173495420507
Financial ratios for CVLG — annual report dated 2025-12-31
Total revenue: 1164472000
Gross profit: 169932000
Operating income: 20467000
Net income: 7239000
Capital expenditures: 112052000
Operating cash flow: 113648000
Depreciation & amortization: 92726000
Net tangible assets: 217910000
Owner earnings: -12087000
Return on net tangible assets (%): -5.5467853701069245
Capex to operating income (%): 547.4764254653833
Buffett classification: The Gruesome
Stock price: 21.99
P/E ratio: 62.18497694571073
Shares outstanding: 20470989
Book value: 403996000
P/B ratio: 1.1142611513727858
Market cap (USD): 450157048.10999995
Debt to equity: 0.8383696868285825
Current ratio: 1.1087875872710475
Quick ratio: 1.078584423130042
Effective tax rate (%): 21.12323376855661
Interest coverage ratio: 1.6978017420157612
COGS to revenue (%): 85.40694838519089
SG&A to revenue (%): 11.652405553761705
Free cash flow (dilution-adjusted): -37492000
Buyback yield (%): 8.12405362829364
Retained earnings: 278210000
Inventory turnover: 156.8180384736676
Receivables turnover: 6.709140667761357
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.449465634237706
FCF margin (%): -3.219656634079652
Revenue growth (%): 2.916190886947668
Rule of 40 score: -0.30346574713198393
Financial ratios for DPZ — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 528.16
Shares outstanding: 33081735
Market cap (USD): 17472449157.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DPZ — annual report dated 2022-12-31
Total revenue: 4537158000
Gross profit: 1648606000
Operating income: 746752000
Net income: 452263000
Capital expenditures: 87234000
Operating cash flow: 475317000
Depreciation & amortization: 80251000
Net tangible assets: -4309182000
Owner earnings: 445280000
Return on net tangible assets (%): -10.333283671935881
Capex to operating income (%): 11.681789938292766
Buffett classification: The Great
Stock price: 328.09
P/E ratio: 23.998837924282995
Shares outstanding: 33081735
Book value: -4189065000
Market cap (USD): 10853786436.15
Debt to equity: -1.253824898873615
Current ratio: 1.4733936987184624
Quick ratio: 1.3213869751649674
Effective tax rate (%): 21.048019230735658
Interest coverage ratio: 3.7666427915704097
COGS to revenue (%): 63.664346712192966
SG&A to revenue (%): 19.87706842036358
Free cash flow (dilution-adjusted): 359374000
Buyback yield (%): 2.706336647841709
Retained earnings: -4194418000
Inventory turnover: 35.411940664459976
Receivables turnover: 17.620578503409813
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 70.07807807807808
FCF margin (%): 7.920685151365679
Rule of 40 score: 7.920685151365679
Financial ratios for DPZ — annual report dated 2023-12-31
Total revenue: 4479358000
Gross profit: 1727417000
Operating income: 819668000
Net income: 519118000
Capital expenditures: 105396000
Operating cash flow: 590864000
Depreciation & amortization: 80640000
Net tangible assets: -4216160000
Owner earnings: 494362000
Return on net tangible assets (%): -11.725408902887937
Capex to operating income (%): 12.858376806219104
Buffett classification: The Great
Stock price: 395.98
P/E ratio: 25.234542869443942
Shares outstanding: 33081735
Book value: -4070367000
Market cap (USD): 13099705425.300001
Debt to equity: -1.279812360900135
Current ratio: 1.493178039645565
Quick ratio: 1.341604092445419
Effective tax rate (%): 20.43436944393354
Interest coverage ratio: 4.171869194554015
COGS to revenue (%): 61.43605847087908
SG&A to revenue (%): 20.265158533879184
Free cash flow (dilution-adjusted): 447954000
Buyback yield (%): 2.0536721343399136
Retained earnings: -4069648000
Inventory turnover: 33.170302781929514
Receivables turnover: 15.838809938863331
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 72.69466781487989
FCF margin (%): 10.00040630822542
Revenue growth (%): -1.2739252192672152
Rule of 40 score: 8.726481088958206
Financial ratios for DPZ — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 417.31
Shares outstanding: 33081735
Market cap (USD): 13805338832.85
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DPZ — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 408.57
Shares outstanding: 33081735
Market cap (USD): 13516204468.949999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DPZ — annual report dated 2024-12-31
Total revenue: 4706416000
Gross profit: 1848502000
Operating income: 879157000
Net income: 584170000
Capital expenditures: 112885000
Operating cash flow: 624897000
Depreciation & amortization: 87732000
Net tangible assets: -4143394000
Owner earnings: 559017000
Return on net tangible assets (%): -13.491765446394913
Capex to operating income (%): 12.840141180699238
Buffett classification: The Great
Stock price: 408.57
P/E ratio: 23.137450517743122
Shares outstanding: 33081735
Book value: -3962291000
Market cap (USD): 13516204468.949999
Debt to equity: -1.3116757451686412
Current ratio: 0.5614259436811534
Quick ratio: 0.5174441320167545
Effective tax rate (%): 19.114114218065257
Interest coverage ratio: 4.488471945678256
COGS to revenue (%): 60.723786422619675
SG&A to revenue (%): 20.596245635744907
Free cash flow (dilution-adjusted): 468757000
Buyback yield (%): 2.438236272298724
Retained earnings: -3956474000
Inventory turnover: 40.29828395775462
Receivables turnover: 15.225995134323723
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 705.8610529020241
FCF margin (%): 9.959956790899913
Revenue growth (%): 5.068985332273062
Rule of 40 score: 15.028942123172975
Financial ratios for DPZ — quarterly report dated 2025-03-31
Total revenue: 1112056000
Gross profit: 443147000
Operating income: 210095000
Net income: 149651000
Capital expenditures: 14745000
Operating cash flow: 179076000
Depreciation & amortization: 20362000
Net tangible assets: -4080924000
Owner earnings: 155268000
Return on net tangible assets (%): -3.804726576628234
Capex to operating income (%): 7.018253647159618
Buffett classification: The Great
Stock price: 449.02
P/E ratio: 24.815003992121667
Shares outstanding: 33081735
Book value: -3912688000
Market cap (USD): 14854360649.699999
Debt to equity: -1.3306708840572006
Current ratio: 0.5987493811735307
Quick ratio: 0.5555871189797025
Effective tax rate (%): 22.251950831766088
Interest coverage ratio: 4.608862564440057
COGS to revenue (%): 60.1506578805384
SG&A to revenue (%): 20.95685828771213
Free cash flow (dilution-adjusted): 153950000
Buyback yield (%): 0.336601494868174
Retained earnings: -3906833000
Inventory turnover: 9.133609153967994
Receivables turnover: 3.6721272499727577
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 116.16507887359766
FCF margin (%): 13.84372729430892
Rule of 40 score: 13.84372729430892
Financial ratios for DPZ — quarterly report dated 2025-06-30
Total revenue: 1145144000
Gross profit: 460970000
Operating income: 221161000
Net income: 131091000
Capital expenditures: 20486000
Operating cash flow: 187784000
Depreciation & amortization: 20351000
Net tangible assets: -4143557000
Owner earnings: 130956000
Return on net tangible assets (%): -3.160472994579295
Capex to operating income (%): 9.262935146793511
Buffett classification: The Great
Stock price: 442.08
P/E ratio: 52.09328639391327
Shares outstanding: 33081735
Book value: -3974627000
Market cap (USD): 14624773408.8
Debt to equity: -1.311211844532833
Current ratio: 0.5968305531219698
Quick ratio: 0.5555405492657481
Effective tax rate (%): 22.086050008618077
Interest coverage ratio: 4.9534357641999645
COGS to revenue (%): 59.74567390651306
SG&A to revenue (%): 20.94138379103414
Free cash flow (dilution-adjusted): 156323000
Buyback yield (%): 1.046450401124932
Retained earnings: -3971182000
Inventory turnover: 9.8152786744136
Receivables turnover: 4.0236115893551085
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 179.64211449736825
FCF margin (%): 13.650946955142759
Revenue growth (%): 2.97538972857482
Rule of 40 score: 16.62633668371758
Financial ratios for DPZ — quarterly report dated 2025-09-30
Total revenue: 1147054000
Gross profit: 459902000
Operating income: 223168000
Net income: 139319000
Capital expenditures: 21436000
Operating cash flow: 185396000
Depreciation & amortization: 20415000
Net tangible assets: -4131961000
Owner earnings: 138298000
Return on net tangible assets (%): -3.347030622989907
Capex to operating income (%): 9.605319759105248
Buffett classification: The Great
Stock price: 425.18
P/E ratio: 33.48487978484078
Shares outstanding: 33081735
Book value: -3961959000
Market cap (USD): 14065692087.300001
Debt to equity: -1.2750548402949147
Current ratio: 1.6094392500830006
Quick ratio: 1.4774637255101983
Effective tax rate (%): 22.25458847426604
Interest coverage ratio: 4.957966764418377
COGS to revenue (%): 59.905810885973985
SG&A to revenue (%): 20.63843550521597
Free cash flow (dilution-adjusted): 153635000
Buyback yield (%): 0.5307737403650991
Retained earnings: -3957671000
Inventory turnover: 9.65711474949055
Receivables turnover: 4.138374673040498
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.90573745633846
FCF margin (%): 13.39387683578977
Revenue growth (%): 0.16679125070733464
Rule of 40 score: 13.560668086497104
Financial ratios for DPZ — quarterly report dated 2025-12-31
Total revenue: 1535740000
Gross profit: 609541000
Operating income: 295522000
Net income: 181643000
Capital expenditures: 63891000
Operating cash flow: 239806000
Depreciation & amortization: 27699000
Net tangible assets: -4087324000
Owner earnings: 145451000
Return on net tangible assets (%): -3.5585874767941075
Capex to operating income (%): 21.619710207700273
Buffett classification: The Great
Stock price: 412.18
P/E ratio: 22.661690020840812
Shares outstanding: 33081735
Book value: -3901142000
Market cap (USD): 13635629532.300001
Debt to equity: -1.294052869646888
Current ratio: 1.6509718050075606
Quick ratio: 1.5047644016757105
Effective tax rate (%): 21.16394538336675
Interest coverage ratio: 4.866402094620185
COGS to revenue (%): 60.309622722596266
SG&A to revenue (%): 20.447406462031335
Free cash flow (dilution-adjusted): 162956000
Buyback yield (%): 0.586690917427016
Retained earnings: -3898622000
Inventory turnover: 11.696056270441602
Receivables turnover: 4.860582735680059
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 25.15427658962342
FCF margin (%): 10.610910701030123
Revenue growth (%): 33.88558864709072
Rule of 40 score: 44.49649934812084
Financial ratios for DPZ — annual report dated 2025-12-31
Total revenue: 4939994000
Gross profit: 1973560000
Operating income: 949946000
Net income: 601704000
Capital expenditures: 120558000
Operating cash flow: 792062000
Depreciation & amortization: 88827000
Net tangible assets: -4087324000
Owner earnings: 569973000
Return on net tangible assets (%): -13.944894018678236
Capex to operating income (%): 12.691037174744672
Buffett classification: The Great
Stock price: 412.18
P/E ratio: 22.661690020840812
Shares outstanding: 33081735
Book value: -3901142000
Market cap (USD): 13635629532.300001
Debt to equity: -1.294052869646888
Current ratio: 1.6509718050075606
Quick ratio: 1.5047644016757105
Effective tax rate (%): 21.890910223823827
Interest coverage ratio: 4.8473557446982225
COGS to revenue (%): 60.049344189486874
SG&A to revenue (%): 20.72095634124252
Free cash flow (dilution-adjusted): 626864000
Buyback yield (%): 2.6232525542930705
Retained earnings: -3898622000
Inventory turnover: 37.46017754991224
Receivables turnover: 15.634970470758772
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 80.85761611388124
FCF margin (%): 12.689570068303727
Revenue growth (%): 4.9629696992361065
Rule of 40 score: 17.652539767539835
Financial ratios for ECG — annual report dated 2024-12-31
Total revenue: 2868593000
Gross profit: 339451000
Operating income: 189907000
Net income: 143421000
Capital expenditures: 13706000
Operating cash flow: 163377000
Depreciation & amortization: 25272000
Net tangible assets: 279388000
Owner earnings: 154987000
Return on net tangible assets (%): 55.473749767348636
Capex to operating income (%): 7.217216848246773
Buffett classification: The Great
Stock price: 65.75
P/E ratio: 23.39954117249217
Shares outstanding: 51041606
Book value: 422612000
P/B ratio: 7.941056085724021
Market cap (USD): 3355985594.5
Debt to equity: 0.8594218810634814
Current ratio: 1.7866821201083039
Quick ratio: 1.701460934608567
Effective tax rate (%): 27.39725269557809
Interest coverage ratio: 13.54253726021536
COGS to revenue (%): 87.50749932109574
SG&A to revenue (%): 5.2131480485380814
Free cash flow (dilution-adjusted): 113540000
Buyback yield (%): 0
Retained earnings: 283972000
Inventory turnover: 57.376777142857144
Receivables turnover: 3.7890373106038093
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.50118888959131
FCF margin (%): 3.95803796495355
Revenue growth (%): -0.029657313402875262
Rule of 40 score: 3.9283806515506745
Financial ratios for ECG — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 65.75
Shares outstanding: 51041606
Market cap (USD): 3355985594.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ECG — quarterly report dated 2025-03-31
Total revenue: 833242000
Gross profit: 92493000
Operating income: 50984000
Net income: 36672000
Capital expenditures: 3310000
Operating cash flow: 7128000
Depreciation & amortization: 6890000
Net tangible assets: 316975000
Owner earnings: 40252000
Return on net tangible assets (%): 12.698793280227147
Capex to operating income (%): 6.492232857367017
Buffett classification: The Great
Stock price: 37.09
P/E ratio: 12.905848921111476
Shares outstanding: 51041606
Book value: 460199000
P/B ratio: 4.113727249602889
Market cap (USD): 1893133166.5400002
Debt to equity: 0.7830482030599806
Current ratio: 1.7785265386792297
Quick ratio: 1.6917036518731947
Effective tax rate (%): 28.96685660627014
Interest coverage ratio: 9.054164446812289
COGS to revenue (%): 88.10597641501509
SG&A to revenue (%): 4.981625986208089
Free cash flow (dilution-adjusted): -13158000
Buyback yield (%): 0
Retained earnings: 320644000
Inventory turnover: 15.488101265822785
Receivables turnover: 1.022735446209061
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.29503597939519
FCF margin (%): -1.579133072984799
Rule of 40 score: -1.579133072984799
Financial ratios for ECG — quarterly report dated 2025-06-30
Total revenue: 925984000
Gross profit: 119869000
Operating income: 72507000
Net income: 52843000
Capital expenditures: 2325000
Operating cash flow: 25342000
Depreciation & amortization: 7127000
Net tangible assets: 371185000
Owner earnings: 57645000
Return on net tangible assets (%): 15.52999178307313
Capex to operating income (%): 3.206586950225496
Buffett classification: The Great
Stock price: 63.53
P/E ratio: 36.22491458615875
Shares outstanding: 51041606
Book value: 514409000
P/B ratio: 6.303686811817056
Market cap (USD): 3242673229.18
Debt to equity: 0.7056797217778071
Current ratio: 1.7727513942381259
Quick ratio: 1.6946154572417362
Effective tax rate (%): 27.884256199534498
Interest coverage ratio: 15.064824433825057
COGS to revenue (%): 86.56704651484259
SG&A to revenue (%): 5.114775201299374
Free cash flow (dilution-adjusted): 11135000
Buyback yield (%): 0
Retained earnings: 373487000
Inventory turnover: 16.6999375
Receivables turnover: 0.9984160922440275
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.362368132419444
FCF margin (%): 1.2025045789128106
Revenue growth (%): 11.130259876482462
Rule of 40 score: 12.332764455395273
Financial ratios for ECG — quarterly report dated 2025-09-30
Total revenue: 990724000
Gross profit: 124222000
Operating income: 72381000
Net income: 56977000
Capital expenditures: 2634000
Operating cash flow: 76170000
Depreciation & amortization: 7292000
Net tangible assets: 429822000
Owner earnings: 61635000
Return on net tangible assets (%): 14.339656881220597
Capex to operating income (%): 3.6390765532391094
Buffett classification: The Great
Stock price: 85.75
P/E ratio: 29.877520373126178
Shares outstanding: 51041606
Book value: 573046000
P/B ratio: 7.6378121730192685
Market cap (USD): 4376817714.5
Debt to equity: 0.6449447339306094
Current ratio: 1.7567160123378631
Quick ratio: 1.6873993646058272
Effective tax rate (%): 28.613262275515584
Interest coverage ratio: 13.302885498989156
COGS to revenue (%): 87.06743755072048
SG&A to revenue (%): 5.232637949620681
Free cash flow (dilution-adjusted): 63756000
Buyback yield (%): 0
Retained earnings: 430464000
Inventory turnover: 17.98690493567154
Receivables turnover: 0.9964916939244346
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.767185115712075
FCF margin (%): 6.435293785151061
Revenue growth (%): 6.991481494280678
Rule of 40 score: 13.42677527943174
Financial ratios for ECG — quarterly report dated 2025-12-31
Total revenue: 1019243000
Gross profit: 117504000
Operating income: 68878000
Net income: 55278000
Capital expenditures: 1702000
Operating cash flow: 48205000
Depreciation & amortization: 7491000
Net tangible assets: 486594000
Owner earnings: 61067000
Return on net tangible assets (%): 12.549887585954615
Capex to operating income (%): 2.4710357443595923
Buffett classification: The Great
Stock price: 85.56
P/E ratio: 21.644049211280173
Shares outstanding: 51041606
Book value: 629818000
P/B ratio: 6.933939343365862
Market cap (USD): 4367119809.36
Debt to equity: 0.5907865446843373
Current ratio: 1.760932639671824
Quick ratio: 1.6994390035181135
Effective tax rate (%): 27.003665329446736
Interest coverage ratio: 13.73713601914639
COGS to revenue (%): 87.7090154163433
SG&A to revenue (%): 4.770795580641711
Free cash flow (dilution-adjusted): 21965000
Buyback yield (%): 0
Retained earnings: 485742000
Inventory turnover: 19.74703452541362
Receivables turnover: 0.9938065220676778
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.93956219440809
FCF margin (%): 2.155030743404664
Revenue growth (%): 2.8786019113294925
Rule of 40 score: 5.0336326547341566
Financial ratios for ECG — annual report dated 2025-12-31
Total revenue: 3769193000
Gross profit: 454088000
Operating income: 264750000
Net income: 201770000
Capital expenditures: 9971000
Operating cash flow: 156845000
Depreciation & amortization: 28800000
Net tangible assets: 486594000
Owner earnings: 220599000
Return on net tangible assets (%): 45.33533089187289
Capex to operating income (%): 3.766194523135033
Buffett classification: The Great
Stock price: 85.56
P/E ratio: 21.644049211280173
Shares outstanding: 51041606
Book value: 629818000
P/B ratio: 6.933939343365862
Market cap (USD): 4367119809.36
Debt to equity: 0.5907865446843373
Current ratio: 1.760932639671824
Quick ratio: 1.6994390035181135
Effective tax rate (%): 28.048066219051943
Interest coverage ratio: 12.342081954221248
COGS to revenue (%): 87.34758342170326
SG&A to revenue (%): 5.023303396774854
Free cash flow (dilution-adjusted): 83698000
Buyback yield (%): 0
Retained earnings: 485742000
Inventory turnover: 72.7242384749619
Receivables turnover: 3.675128096373325
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 26.67396107566337
FCF margin (%): 2.2205814348058057
Revenue growth (%): 31.395182237424407
Rule of 40 score: 33.615763672230216
Financial ratios for EMA.AX — annual report dated 2022-06-30
Operating income: -2096889.655172414
Net income: -2096889.655172414
Capital expenditures: 11580
Depreciation & amortization: 19868.275862068967
Net tangible assets: 11467142.068965517
Owner earnings: -2088601.379310345
Return on net tangible assets (%): -18.213791777838885
Buffett classification: The Gruesome
Stock price: 0.09655172413793105
Shares outstanding: 155628951
Book value: 11493080
P/B ratio: 1.3074165971895773
Market cap (USD): 15026243.544827588
Debt to equity: 0.0037499026400653925
Current ratio: 38.12550971676279
Quick ratio: 38.12550971676279
Free cash flow (dilution-adjusted): -1369679.3103448276
Buyback yield (%): 3.1437595438139265
Retained earnings: -1525682.7586206896
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -18.22422627101135
Rule of 40 score: 0
Financial ratios for EMA.AX — annual report dated 2023-06-30
Total revenue: 1362.9139072847681
Gross profit: 1362.9139072847681
Operating income: -812025.1655629139
Net income: -810662.2516556291
Capital expenditures: 16349.668874172185
Depreciation & amortization: 42088.079470198674
Net tangible assets: 10214674.17218543
Owner earnings: -784923.8410596026
Return on net tangible assets (%): -7.684276833782433
Buffett classification: The Gruesome
Stock price: 0.0728476821192053
Shares outstanding: 155628951
Book value: 10214674.17218543
P/B ratio: 1.109894271700277
Market cap (USD): 11337208.350993376
Debt to equity: 0.008193769799297958
Current ratio: 10.736515839432336
Quick ratio: 10.736515839432336
COGS to revenue (%): 0
SG&A to revenue (%): 16458.892128279884
Free cash flow (dilution-adjusted): -1186629.8013245033
Buyback yield (%): 0
Retained earnings: -2275721.854304636
Receivables turnover: 0.03250209257884679
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.912970093924403
FCF margin (%): -87065.6462585034
Rule of 40 score: -87065.6462585034
Financial ratios for EMA.AX — annual report dated 2024-06-30
Total revenue: 12470.666666666666
Gross profit: 12470.666666666666
Operating income: -1165459.3333333333
Net income: -1165459.3333333333
Capital expenditures: 2641.3333333333335
Depreciation & amortization: 42629.333333333336
Net tangible assets: 12587056.666666666
Owner earnings: -1125471.3333333333
Return on net tangible assets (%): -8.941497310597104
Buffett classification: The Gruesome
Stock price: 0.21333333333333335
Shares outstanding: 155628951
Book value: 12587056.666666668
P/B ratio: 2.637697101016732
Market cap (USD): 33200842.880000003
Debt to equity: 0.0038734498957527005
Current ratio: 12.102619109255237
Quick ratio: 12.102619109255237
COGS to revenue (%): 0
SG&A to revenue (%): 3705.2817277878758
Free cash flow (dilution-adjusted): -2816481.3333333335
Buyback yield (%): 0.6640955897723683
Retained earnings: -3438714
Receivables turnover: 0.31543624161073824
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.254362698235946
FCF margin (%): -22584.84978081899
Revenue growth (%): 815.0003239390994
Rule of 40 score: -21769.84945687989
Financial ratios for EMEIS.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6393.659090909091
Shares outstanding: 161033655
Market cap (USD): 1029594292233.0682
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMEIS.PA — annual report dated 2022-12-31
Total revenue: 4979679787.234043
Gross profit: 3980470212.765958
Operating income: -706690425.531915
Net income: -4284087234.0425534
Capital expenditures: 145011702.1276596
Operating cash flow: 435879787.2340426
Depreciation & amortization: 856512765.9574468
Net tangible assets: -4740685106.382979
Owner earnings: -3572586170.2127666
Buffett classification: The Gruesome
Stock price: 419.3297872340426
Shares outstanding: 161033655
Book value: -1598123404.2553196
Market cap (USD): 67526208288.67022
Debt to equity: -8.908895140310841
Current ratio: 0.22639659142759977
Quick ratio: 0.22478945229596797
Interest coverage ratio: -1.988436762892276
COGS to revenue (%): 20.06573950858585
Free cash flow (dilution-adjusted): 290868085.10638297
Buyback yield (%): 0
Retained earnings: -4284087234.0425534
Inventory turnover: 58.33894409937888
Receivables turnover: 10.27937624075473
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.83903192421626
FCF margin (%): 5.841100181824046
Rule of 40 score: 5.841100181824046
Financial ratios for EMEIS.PA — annual report dated 2023-12-31
Total revenue: 5775287777.777778
Gross profit: 4583462222.222222
Operating income: -134093333.33333333
Net income: 1511852222.222222
Capital expenditures: 156715555.55555555
Operating cash flow: 406827777.7777778
Depreciation & amortization: 911631111.111111
Net tangible assets: -1124863333.3333333
Owner earnings: 2266767777.7777777
Return on net tangible assets (%): -201.51494947040482
Buffett classification: The Gruesome
Stock price: 18.655555555555555
P/E ratio: 1.9870806504824474
Shares outstanding: 161033655
Book value: 2098253333.333332
P/B ratio: 1.4317490883687392
Market cap (USD): 3004172297.1666665
Debt to equity: 4.851122203229356
Current ratio: 0.7592220803180477
Quick ratio: 0.7542340026183564
Effective tax rate (%): 3.1846647101247476
Interest coverage ratio: -0.2074666969226564
COGS to revenue (%): 20.636643599674397
Free cash flow (dilution-adjusted): 250112222.2222222
Buyback yield (%): 0
Retained earnings: 1505443333.3333333
Inventory turnover: 68.90050102774924
Receivables turnover: 10.032288946406409
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.118795493595136
FCF margin (%): 4.33073176343882
Revenue growth (%): 15.977091390160531
Rule of 40 score: 20.30782315359935
Financial ratios for EMEIS.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -1293143750
Buffett classification: The Gruesome
Stock price: 6.3125
Shares outstanding: 161033655
Book value: 1793671875
P/B ratio: 0.5667284866065595
Market cap (USD): 1016524947.1875
Debt to equity: 5.197656111619263
Current ratio: 0.7166404476008125
Quick ratio: 0.7104530784181956
Buyback yield (%): 0
Retained earnings: -429234375
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMEIS.PA — annual report dated 2024-12-31
Total revenue: 5870625000
Gross profit: 4697270833.333334
Operating income: 1892708.3333333335
Net income: -429234375
Capital expenditures: 149415625
Operating cash flow: 491721875
Depreciation & amortization: 721514583.3333334
Net tangible assets: -1293143750
Owner earnings: 142864583.33333337
Capex to operating income (%): 7894.276279581727
Buffett classification: The Gruesome
Stock price: 6.3125
Shares outstanding: 161033655
Book value: 1793671875
P/B ratio: 0.5667284866065595
Market cap (USD): 1016524947.1875
Debt to equity: 5.197656111619263
Current ratio: 0.7166404476008125
Quick ratio: 0.7104530784181956
Interest coverage ratio: 0.004554786536682702
COGS to revenue (%): 19.986869654707405
Free cash flow (dilution-adjusted): 342306250
Buyback yield (%): 0
Retained earnings: -429234375
Inventory turnover: 69.395022178413
Receivables turnover: 10.755712982507031
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.016847198413822824
FCF margin (%): 5.830831470243798
Revenue growth (%): 1.650778729833378
Rule of 40 score: 7.481610200077176
Financial ratios for ERC — annual report dated 2021-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.68
Shares outstanding: 28053801
Market cap (USD): 243506992.67999998
Buyback yield (%): 1.5188360544784336
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ERC — annual report dated 2022-10-31
Total revenue: -55920952
Net income: -56240422
Capital expenditures: 0
Operating cash flow: 51770240
Depreciation & amortization: 312626
Net tangible assets: 265673401
Owner earnings: -55927796
Return on net tangible assets (%): -21.051334378784876
Buffett classification: The Gruesome
Stock price: 6.47
Shares outstanding: 28053801
Book value: 265673401
P/B ratio: 0.6832000937496938
Market cap (USD): 181508092.47
Debt to equity: 0.4479183823148332
Free cash flow (dilution-adjusted): 51770240
Buyback yield (%): 0.37183355894258546
Retained earnings: -109377585
Receivables turnover: -7.453129781410569
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ERC — annual report dated 2023-10-31
Total revenue: 20735933
Net income: 20262012
Capital expenditures: 0
Operating cash flow: 22861351
Depreciation & amortization: 0
Net tangible assets: 263296934
Owner earnings: 20262012
Return on net tangible assets (%): 7.695498649444965
Buffett classification: The Gruesome
Stock price: 6.84
P/E ratio: 9.470332898825646
Shares outstanding: 28053801
Book value: 263296934
P/B ratio: 0.7287893403270697
Market cap (USD): 191887998.84
Debt to equity: 0.4519612066580312
COGS to revenue (%): 0
SG&A to revenue (%): 2.06983211220831
Free cash flow (dilution-adjusted): 22861351
Buyback yield (%): 0
Retained earnings: -102929671
Receivables turnover: 2.721602500900379
Capitalized R&D asset: 0
FCF margin (%): 110.24992702281591
Rule of 40 score: 110.24992702281591
Financial ratios for ERC — annual report dated 2024-10-31
Total revenue: 38475737
Net income: 37950086
Capital expenditures: 0
Operating cash flow: 22097615
Depreciation & amortization: 0
Net tangible assets: 279082978
Owner earnings: 37950086
Return on net tangible assets (%): 13.598137110318495
Buffett classification: The Gruesome
Stock price: 7.81
P/E ratio: 5.773377847154285
Shares outstanding: 28053801
Book value: 279082978
P/B ratio: 0.7850718355527939
Market cap (USD): 219100185.81
Debt to equity: 0.4263964819810687
COGS to revenue (%): 0
SG&A to revenue (%): 1.2894099988260135
Free cash flow (dilution-adjusted): 22097615
Buyback yield (%): 0.05048877507385077
Retained earnings: -85796152
Receivables turnover: 4.433713763078629
Capitalized R&D asset: 0
FCF margin (%): 57.432597067601336
Revenue growth (%): 85.5510287383741
Rule of 40 score: 142.98362580597544
Financial ratios for ERC — quarterly report dated 2024-10-31
Capital expenditures: 0
Net tangible assets: 279082978
Buffett classification: The Gruesome
Stock price: 7.81
Shares outstanding: 28053801
Book value: 279082978
P/B ratio: 0.7850718355527939
Market cap (USD): 219100185.81
Debt to equity: 0.4263964819810687
Buyback yield (%): 0
Retained earnings: -85796152
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ERC — quarterly report dated 2025-04-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.25
Shares outstanding: 28053801
Market cap (USD): 231443858.25
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FBK — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 40.85
Shares outstanding: 51523462
Market cap (USD): 2104733422.7
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FBK — annual report dated 2022-12-31
Total revenue: 527167000
Net income: 124571000
Capital expenditures: 9754000
Operating cash flow: 799713000
Depreciation & amortization: 12602000
Net tangible assets: 902023000
Owner earnings: 127419000
Return on net tangible assets (%): 14.125914749402178
Buffett classification: The Gruesome
Stock price: 34.11
P/E ratio: 14.108141452023345
Shares outstanding: 51523462
Book value: 1325518000
P/B ratio: 1.3258705568841767
Market cap (USD): 1757465288.82
Debt to equity: 0.37343061354127216
Effective tax rate (%): 21.93527767681452
COGS to revenue (%): 0
SG&A to revenue (%): 42.24448798957446
Free cash flow (dilution-adjusted): 779227000
Buyback yield (%): 2.2748102198275997
Retained earnings: 586532000
Receivables turnover: 6.044176154278311
Capitalized R&D asset: 0
FCF margin (%): 147.81407030409719
Rule of 40 score: 147.81407030409719
Financial ratios for FBK — annual report dated 2023-12-31
Total revenue: 477787000
Net income: 120240000
Capital expenditures: 20106000
Operating cash flow: 211072000
Depreciation & amortization: 14839000
Net tangible assets: 1038750000
Owner earnings: 114973000
Return on net tangible assets (%): 11.068399518652226
Buffett classification: The Gruesome
Stock price: 38.32
P/E ratio: 16.420318228875583
Shares outstanding: 51523462
Book value: 1454887000
P/B ratio: 1.357066950106778
Market cap (USD): 1974379063.84
Debt to equity: 0.24715940138306275
Effective tax rate (%): 19.995741622973945
COGS to revenue (%): 0
SG&A to revenue (%): 44.310121455795155
Free cash flow (dilution-adjusted): 180462000
Buyback yield (%): 0.25040784166260044
Retained earnings: 678412000
Receivables turnover: 5.0162944764664505
Capitalized R&D asset: 0
FCF margin (%): 37.77038722275826
Revenue growth (%): -9.367050668953102
Rule of 40 score: 28.403336553805158
Financial ratios for FBK — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 45.72
Shares outstanding: 51523462
Market cap (USD): 2355652682.64
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FBK — annual report dated 2024-12-31
Total revenue: 455573000
Net income: 116051000
Capital expenditures: 5537000
Operating cash flow: 138800000
Depreciation & amortization: 14913000
Net tangible assets: 1155789000
Owner earnings: 125427000
Return on net tangible assets (%): 10.852067289098615
Buffett classification: The Gruesome
Stock price: 50.36
P/E ratio: 22.35845918018802
Shares outstanding: 51523462
Book value: 1567631000
P/B ratio: 1.6551864222639128
Market cap (USD): 2594721546.32
Debt to equity: 0.14866508763860883
Effective tax rate (%): 20.87611645189882
COGS to revenue (%): 0
SG&A to revenue (%): 41.88571315683765
Free cash flow (dilution-adjusted): 122769000
Buyback yield (%): 0.4894166781792263
Retained earnings: 762293000
Receivables turnover: 4.046516378881546
Capitalized R&D asset: 0
FCF margin (%): 26.948260761722054
Revenue growth (%): -4.649352117156808
Rule of 40 score: 22.298908644565245
Financial ratios for FBK — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 50.36
Shares outstanding: 51523462
Market cap (USD): 2594721546.32
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FBK — quarterly report dated 2025-03-31
Total revenue: 130673000
Net income: 39361000
Capital expenditures: 168000
Operating cash flow: -16458000
Depreciation & amortization: 3423000
Net tangible assets: 1197916000
Owner earnings: 42616000
Return on net tangible assets (%): 3.5575115450499033
Buffett classification: The Gruesome
Stock price: 45.49
P/E ratio: 14.886577363252968
Shares outstanding: 51523462
Book value: 1602055000
P/B ratio: 1.4629973917125192
Market cap (USD): 2343802286.38
Debt to equity: 0.14239086673054296
Effective tax rate (%): 19.39506880733945
COGS to revenue (%): 0
SG&A to revenue (%): 38.90474696379512
Free cash flow (dilution-adjusted): -22952000
Buyback yield (%): 0.4220492512309211
Retained earnings: 792685000
Receivables turnover: 2.548821877194351
Capitalized R&D asset: 0
FCF margin (%): -17.56445478407934
Rule of 40 score: -17.56445478407934
Financial ratios for FBK — quarterly report dated 2025-06-30
Total revenue: 76863000
Net income: 2917000
Capital expenditures: 3387000
Operating cash flow: 71782000
Depreciation & amortization: 3499000
Net tangible assets: 1210630000
Owner earnings: 3029000
Return on net tangible assets (%): 0.25020030893006123
Buffett classification: The Gruesome
Stock price: 44.63
P/E ratio: 54.38980342163774
Shares outstanding: 51523462
Book value: 1611223000
P/B ratio: 1.4271718496198231
Market cap (USD): 2299492109.06
Debt to equity: 0.13888456160320453
COGS to revenue (%): 0
SG&A to revenue (%): 63.50129451101311
Free cash flow (dilution-adjusted): 65394000
Buyback yield (%): 1.4896332918490665
Retained earnings: 786785000
Receivables turnover: 1.5254832691620688
Capitalized R&D asset: 0
FCF margin (%): 85.07864642285625
Revenue growth (%): -41.17912652192878
Rule of 40 score: 43.89951990092747
Financial ratios for FBK — quarterly report dated 2025-09-30
Total revenue: 173875000
Net income: 23375000
Capital expenditures: 2146000
Operating cash flow: 47725000
Depreciation & amortization: 5264000
Net tangible assets: 1444634000
Owner earnings: 26493000
Return on net tangible assets (%): 1.8338901064214188
Buffett classification: The Gruesome
Stock price: 55.14
P/E ratio: 43.27302171538239
Shares outstanding: 51523462
Book value: 1978136000
P/B ratio: 1.4362024121091777
Market cap (USD): 2841003694.68
Debt to equity: 0.08534094723517494
Effective tax rate (%): 21.03574082832241
COGS to revenue (%): 0
SG&A to revenue (%): 35.46398274622574
Free cash flow (dilution-adjusted): 41825000
Buyback yield (%): 0.8400904245458326
Retained earnings: 799900000
Receivables turnover: 2.8619043700106985
Capitalized R&D asset: 0
FCF margin (%): 24.054636951833213
Revenue growth (%): 126.21417326932334
Rule of 40 score: 150.26881022115654
Financial ratios for FBK — annual report dated 2025-12-31
Total revenue: 561176000
Net income: 122638000
Capital expenditures: 6999000
Operating cash flow: 155863000
Depreciation & amortization: 17352000
Net tangible assets: 1416840000
Owner earnings: 132991000
Return on net tangible assets (%): 9.386451540046865
Buffett classification: The Gruesome
Stock price: 55.39
P/E ratio: 23.270801547481206
Shares outstanding: 51523462
Book value: 1948258000
P/B ratio: 1.4648391333078064
Market cap (USD): 2853884560.18
Debt to equity: 0.0941050928573115
Effective tax rate (%): 11.464214037164846
COGS to revenue (%): 0
SG&A to revenue (%): 40.50476142956933
Free cash flow (dilution-adjusted): 129706000
Buyback yield (%): 5.463220277913631
Retained earnings: 846620000
Receivables turnover: 4.219304972857551
Capitalized R&D asset: 0
FCF margin (%): 23.113247893708923
Revenue growth (%): 23.18025870716658
Rule of 40 score: 46.2935066008755
Financial ratios for FBK — quarterly report dated 2025-12-31
Total revenue: 179765000
Net income: 56985000
Capital expenditures: 1634000
Operating cash flow: 52814000
Depreciation & amortization: 5166000
Net tangible assets: 1416840000
Owner earnings: 60517000
Return on net tangible assets (%): 4.2712656333813275
Buffett classification: The Gruesome
Stock price: 55.39
P/E ratio: 23.270801547481206
Shares outstanding: 51523462
Book value: 1948258000
P/B ratio: 1.4648391333078064
Market cap (USD): 2853884560.18
Debt to equity: 0.0941050928573115
Effective tax rate (%): 18.381815838095648
COGS to revenue (%): 0
SG&A to revenue (%): 36.71070564347899
Free cash flow (dilution-adjusted): 45439000
Buyback yield (%): 3.080047498293201
Retained earnings: 846620000
Receivables turnover: 1.3515962165982467
Capitalized R&D asset: 0
FCF margin (%): 25.276889272105247
Revenue growth (%): 3.3874910136592375
Rule of 40 score: 28.664380285764484
Financial ratios for FISK — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.98
Shares outstanding: 2173501
Market cap (USD): 17344537.98
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FISK — annual report dated 2022-12-31
Total revenue: 727041000
Gross profit: 405687000
Operating income: 127028000
Net income: 126424000
Capital expenditures: 35000
Operating cash flow: 211173000
Depreciation & amortization: 219966000
Net tangible assets: 847073000
Owner earnings: 346355000
Return on net tangible assets (%): 40.88844763084173
Capex to operating income (%): 0.027552980445256163
Buffett classification: The Great
Stock price: 6.33
P/E ratio: 0.10882634096374105
Shares outstanding: 2173501
Book value: 1683091000
P/B ratio: 0.008174401342529905
Market cap (USD): 13758261.33
Debt to equity: 1.362169959913041
Current ratio: 1.2277130795618236
Quick ratio: 1.2277130795618236
Effective tax rate (%): 2.387349825504185
Interest coverage ratio: 1.2551429757129025
COGS to revenue (%): 44.200258307303166
SG&A to revenue (%): 8.495394345023183
Free cash flow (dilution-adjusted): 190162000
Buyback yield (%): 655.4316554764846
Receivables turnover: 2.750921336410761
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.4678063315829775
FCF margin (%): 26.155608830863734
Rule of 40 score: 26.155608830863734